
09-15-2016, 05:30 PM
|
|
Administrator
|
|
تاريخ التسجيل: Sep 2012
المشاركات: 3,727,761
|
|
BRIEF-Merck, Pfizer say investigational Ertugliflozin met primary endpoint
BRIEF-Merck, Pfizer say investigational Ertugliflozin met primary endpoint
* Merck and Pfizer an**unce investigational Ertugliflozinmet primary endpoint of A1C reduction when added to Sitagliptinand Metformin in people with type 2 diabetes
|